Advisor Group Holdings, Inc. Virios Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.24 - $0.44 $3,022 - $5,540	12,592 Added 45.25%	40,421 $14,000
Q4 2022 Feb 10, 2023	BUY	$0.24 - $0.39 $4,609 - $7,491	19,208 Added 222.8%	27,829 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.37 - $8.77 $2,526 - $59,890	6,829 Added 381.08%	8,621 $3,000
Q2 2022 Aug 10, 2022	BUY	$3.31 - $4.89 $347 - $513	105 Added 6.22%	1,792 $8,000
Q1 2022 May 04, 2022	SELL	$4.48 - $6.92 $542 - $837	-121 Reduced 6.69%	1,687 $8,000
Q3 2021 Nov 05, 2021	BUY	$4.61 - $6.56 $1,097 - $1,561	238 Added 15.16%	1,808 $10,000
Q2 2021 Aug 02, 2021	SELL	$4.71 - $6.95 $9,580 - $14,136	-2,034 Reduced 56.44%	1,570 $10,000
Q1 2021 May 13, 2021	BUY	$5.01 - $8.84 $15,961 - $28,164	3,186 Added 762.2%	3,604 $21,000
Q4 2020 Feb 10, 2021	BUY	$7.51 - $16.71 $3,139 - $6,984	418 New	418 $3,000

1.12M

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.